Background: This study evaluated risk factors associated with 30-day readmission after open and endovascular lower extremity revascularization. Methods: Patients admitted with peripheral artery disease and lower extremity procedures were selected from national electronic medical record data, Cerner Health FactsV R (2008)(2009)(2010)(2011)(2012)(2013)(2014). Thirty-day readmission was determined. Logistic regression models identified characteristics independently associated with readmission. Results: There were 2781 open and 2611 endovascular procedures. Readmission was 10.9% (9.6% open versus 12.3% endovascular, p<.0001). Greater disease severity was associated with readmission for both groups. Readmission factors for lower extremity bypass: blood transfusions (OR 2.25, 95% CI 1.62-3.13), hyponatremia (OR 1.72, 95% CI 1.15-2.57), heart failure (OR 1.57, 95% CI 1.07-2.29), bronchodilators (OR 1.50, 95% CI 1.13-2.00), black race (OR 1.43, 95% CI 1.03-1.99), and hypokalemia (OR 0.43, 95% CI 0.20-0.95). Readmission factors for endovascular procedures: vasodilators (OR 1.63, 95% CI 1.22-2.16), end-stage renal disease (OR 1.43, 95% CI 1.02-2.01), fluid and electrolyte disorders (OR 1.44, 95% CI 1.00-2.06), hypertension (OR 1.33, 95% CI 0.99-1.76), coronary artery disease (OR 1.31, 95% CI 1.02-1.67), and diuretics (OR 1.30, 95% CI 1.01-1.70). Conclusions: Readmission after lower extremity revascularization is associated with disease severity for both procedures. Factors associated with readmission following lower extremity bypass included heart failure, transfusions, hyponatremia, black race, and bronchodilator use. Risk factors for endovascular readmissions were often chronic conditions including coronary artery disease, kidney disease, hypertension, and hypertensive medications. Awareness of risk factors may help providers identify high-risk patients who may benefit from increased surveillance and programs to lower readmission.
Introduction
It has been estimated that that unplanned rehospitalizations cost Medicare $17.4 billion or more annually. 1 The increasing cost of hospital readmissions has driven national efforts to reduce these events, including decreased reimbursements for institutions with higher readmission rates. As well, lowering 30-day readmission rates after vascular interventions offers potential to improve healthcare quality. 2 Specific risk factors associated with readmission following lower extremity (LE) vascular procedures remain poorly defined, warranting further investigation. 1, 3, 4 Despite increased utilization of minimally invasive procedures, there is little information on causes for readmission and readmission rates after endovascular procedures. Readmission is a multifactorial problem that varies with characteristics of patients and treatment received during the index admission. Thus, there is a knowledge gap regarding utilizing index stay information to predict future readmissions. 5 Improved opportunities to reduce unplanned readmissions are essential. Strategies to reduce readmission will include assessing patients to identify those at highest risk for readmission. Understanding the diagnoses, medications, and laboratory values associated with readmission after revascularization for peripheral artery disease (PAD) may offer potential targets for reducing readmission and associated costs.
This analysis evaluates the readmission rates after LE interventions using a national electronic medical record data set, compares rates between open bypass and endovascular procedures for PAD, and evaluates detailed clinical factors associated with readmission for each procedure type. In addition to risk factors typically present in administrative databases, our national data set also had detailed information on medications and laboratory studies. The objective of this analysis is to describe characteristics of the index admission that are associated with readmission and to define the diagnoses present on readmission after LE procedures.
Methods

Overall
We conducted a retrospective cohort study of adults admitted for PAD who underwent LE procedures. Patients admitted between September 2008 and March 2014 were selected from the Cerner Health FactsV R database using International Classification of Diseases, Ninth Revision, Clinical Modification diagnosis and procedure codes (index admission). We used the Agency for Healthcare Research and Quality's Clinical Classifications Software to group diagnosis codes into clinically relevant groups. The study was approved by the Health Sciences Institutional Review Board at the University of Missouri. Informed patient consent was not needed as the Cerner Health FactsV R database is completely deidentified using methods that are compliant with the Health Insurance Portability and Accountability Act.
Data source
Health Facts is a proprietary database comprised of electronic medical records from hospitals and hospital systems that use Cerner Corporation's electronic health record and that elect to participate. Hospitals choose what types of data to contribute. For example, hospitals may not contribute billing data for any of their patients. Categories of data hospitals may contribute potentially include billing data, diagnoses and procedures, encounter data, medication orders, and diagnostic test results. All data were collected as part of providing medical care in participating facilities. Cerner deidentifies and standardizes the data before including them in Health Facts. Rigorous validity checks are applied to the data. We excluded: (1) admissions for patients less than 21 years old at admission, (2) admissions during which both endovascular and open procedures were performed, (3) hospital stays longer than 30 days, (4) admissions flagged as emergent or urgent, (5) patients who died in the hospital or were discharged to hospice, (6) encounters with an adjacent encounter within 3 h of admission or discharge, and (7) admissions with no reported laboratory or medication data. We identified patients readmitted within 30 days of their discharge from the index admission.
Study population
Statistical analysis
We used SAS for Windows, version 9.4, for all analyses (SAS Institute, Cary, NC). We used chi-square analysis or independent t-tests (for categorical or continuous variables, respectively) to compare the characteristics of patients who received open or endovascular procedures and to determine characteristics of the index admission associated with readmission. Relative risks (RR) and 95% confidence intervals (CI) were calculated. We also examined patients' diagnoses recorded during the readmission stay and determined if they were associated with the type of procedure received during the index admission.
To account for nonrandom assignment of procedure type, a propensity score was used to adjust for the probability of receiving an open procedure. We allowed age, race, gender, marital status, PAD severity, hospital bed size, teaching facility, index diagnoses, Charlson index, 6 and preoperative medications to enter a stepwise logistic model (entry and exit p-value ¼ .10). The estimated probability of having an open procedure was used as a covariate in the overall readmission model.
Associations of index admission diagnoses, postoperative medications, and laboratory results with 30-day readmission were then modeled using three separate logistic regression models-one for all patients and separate models for open and endovascular procedures. We initially created a base model that included the propensity score, procedure type (open versus endovascular), patient characteristics (age, sex, race/ethnicity, and disease severity), hospital characteristics (bed size and teaching facility), and length of stay. The procedure-specific base models excluded the propensity score and procedure type. Comorbid diagnoses, postoperative medications, laboratory values, and encounter characteristics were allowed to enter into each base model using stepwise selection (entry and exit p-value ¼ .10). Backward elimination models were also run to determine whether the same variables were retained in the final models. Odds ratios and 95% CIs were calculated. Model discrimination was assessed with the c-statistic, where 1 indicates perfect fit and .5 is no better than a coin toss.
Model calibration was assessed with the HosmerLemeshow goodness-of-fit test, where p>.05 indicates adequate fit over the range of predicted readmission.
Results
Overall
We identified 5392 patients who underwent elective LE procedures (Figure 1 ). The mean age of patients was 67.5 years (95% CI of the mean 67.2-67.8); almost half (44.0%) of patients were age 70 years or older (Table 1 ). Over half (59.7%) of patients were men. Most patients (73.7%) were White and 21.6% were African American. Most patients (77.4%) were discharged to home, 10.5% went to an intermediate care or skilled nursing facility (ICF/SNF), and 3.2% were discharged to a rehabilitation facility. Readmission differed by discharge location; 71.0% of readmitted patients had been discharged to home compared with 78.2% of patients who were not readmitted (Table 1) . In contrast, 14.5% of readmitted patients were discharged to an ICF/SNF compared with 10.0% of patients who were not readmitted (p=.0008). There were 71 hospitals represented in the sample. All were Considering the diagnoses present at the time of readmission (Table 4 ), chronic problems (e.g. chronic kidney disease, chronic heart disease, end-stage renal disease, diabetes, anemia, and hypertension) and LE cellulitis were more likely to be associated with having had an endovascular procedure during the index stay. Readmission patients with posthemorrhagic anemia were more likely to have had an open procedure during their index encounter.
Models
The propensity model had a c-statistic of 0.71 and a nonsignificant goodness-of-fit statistic (v 2 ¼ 9.01, p ¼ .34). Odds ratios and 95% CIs for multivariable analysis of readmission are shown in Table 5 . Forward selection and backward elimination selected the same variables for all models. In all models, age and gender were unrelated to readmission and increased disease severity was associated with greater odds of readmission. In the propensity-adjusted model, having an open procedure was associated with lower odds of readmission (OR 0.77, 95% CI 0.63-0.93).
For readmission following either type of procedure, the following variables were retained in the base model (beyond those we automatically included): having had a transfusion (OR 1.65, 95% CI 1.28-2.13), low postoperative serum sodium (OR 
Discussion
Overall, this analysis has demonstrated that disease severity, receiving a transfusion, hyponatremia, use of steroids, chronic kidney disease, coronary artery disease, and receiving vasodilators or bronchodilators were associated with greater odds of readmission for both open and endovascular LE procedures. For open LE bypass, receiving a blood transfusion, heart failure, use of bronchodilators, hyponatremia, hypokalemia, and black race were significant risk factors for 30-day readmission. Risk factors specific for readmission after an endovascular LE procedure included coronary artery disease, use of vasodilators, use of diuretics, hypertension, end-stage renal disease, and fluid and electrolyte disorders.
The factor most strongly associated with readmission after any LE procedure was severity of disease. Patients with gangrene had 2.5 times the odds of readmission, and those with ulceration had 1.6 times greater odds. The higher odds of readmission among patients with more severe disease are likely related to overall health status, need for secondary procedures, or worsening status. Previous analyses corroborate that disease severity is associated with readmission. 7, 8 Overall, the most important medications associated with readmission were the use of steroids, vasodilators, and bronchodilators. The odds of 30-day readmission were 39% higher for patients taking steroid medications. Previous studies in other surgical specialties have found similar results with steroid utilization, mortality, and serious postoperative complications. This analysis reports the association of steroids to readmission, which has been previously described for other surgical procedures. 9 For open LE bypass procedures, a diagnosis of heart failure during the index hospitalization was highly associated with 30-day readmission after controlling for other risk factors. This may represent an acute event at the index admission or may be an exacerbation of preexisting congestive heart failure. McPhee et al. evaluated 1516 LE bypasses from a prospective institutional registry and examined patients who had an unplanned readmission. Using multivariable analysis, they found that preoperative factors associated with unplanned readmission included dialysis dependence, tissue loss indication, and history of congestive heart failure. 10, 11 For bypass surgery, patients receiving a blood transfusion during the index admission had 2.25 times the odds of readmission. When evaluating general surgery patients, events leading to increased risk of 30-day readmission were blood transfusions and vascular complications. 12 Reasons for this association are unclear but may represent a bleeding complication during the index visit or transfusion-related morbidity 13 and subsequent readmission. As well, patients utilizing bronchodilators had 1.5 the odds of readmission after open bypass. This may be associated with underlying pulmonary dysfunction and COPD. It has been well established that medical patients with a primary disease diagnosis of CHF and COPD are at increased risk of readmission.
14 Furthermore, patients with fluid and electrolyte disorders, particularly hyponatremia (sodium <135 mEq/l) were more likely to be readmitted. Other investigators have reported predictors of readmissions within 30 days of hospital discharge for diabetic Medicare home healthcare with fluid and electrolyte diseases and depression and/or anxiety. 15 We also found that depressive disorders were associated with readmission after open bypass surgery. Odonkor et al. 16 have suggested that depressive symptom severity moderated the association of sociodemographic, social support, and physical function indicators with 30-day readmissions. Finally, race was associated with increased readmission after LE bypass as the odds of 30-day readmission were 43% higher for blacks compared to whites. Racial disparities have been described for many surgical procedures 17, 18 and race is likely a surrogate for sociodemographic disparities and other factors which lead to the development of inferior outcomes. 19, 20 Patients who underwent endovascular procedures were more likely to be readmitted than patients who underwent open procedures. Other authors have reported that readmission after endovascular treatment is relatively common, especially in patients with critical limb ischemia. 21 Chronic conditions including endstage renal disease, fluid and electrolyte disorders, and coronary artery disease during the index admission were associated with increased readmission at 30 days. As well, the use of vasodilators and diuretics was associated with readmission after endovascular procedures, consistent with the finding that hypertension is associated with increased readmission. Other authors have found chronic conditions associated with readmission after infrainguinal endovascular procedures including diabetes, congestive heart failure, renal insufficiency, and preoperative dialysis. 21 Curran et al. 22 evaluated risk factors for readmission and postdischarge adverse events and suggested that optimization of medical comorbidities may play a role in decreasing readmission and postdischarge adverse events. This phenomenon has been previously described-regardless of payer or age group-readmission within 30 days following nonsurgical hospitalizations for chronic conditions was higher than the readmission rate for acute conditions. 23 Therefore, as we preform endovascular procedures on more patients with multiple chronic conditions using lower thresholds for intervention, we may continue to see substantial rates of readmission in the vascular population if chronic conditions cannot be better managed in the postprocedure setting. This also suggests that penalties for elevated readmission rates in the presence of existing patient conditions may be ineffective for reducing readmissions.
A secondary evaluation of the diagnosis codes recorded at the time of readmission demonstrated that patients with posthemorrhagic anemia had more often received open LE bypass during the index admission, suggesting a complication secondary to surgery, whereas chronic conditions were more commonly documented upon readmission following endovascular procedures. Chronic conditions most often seen in the postendovascular readmission group included chronic kidney disease, end-stage renal disease, chronic anemia, and diabetes.
This study has limitations secondary to relying on ICD-9 codes, as coding may vary between institutions. Because procedure type was not randomly assigned, confounding could explain the differences between groups, and this was addressed with a propensity score analysis. As well, all of the procedures were performed during inpatient admissions as no outpatient facilities contributed data. As Cerner Corporations' Health Facts is a proprietary database comprised of electronic clinical records from hospitals and hospital systems that use Cerner's electronic health record, the ethnicity and patient mix may not represent the entire US population. It is also possible that hospitals that do not contribute certain types of data (e.g. laboratory or medication data) might differ from hospitals that do contribute these data. Proportions by ethnicity, however, are comparable to previously published evaluations of LE procedures utilizing Medicare data, which is considered a representative sample of the elderly US population. Patients of smaller and rural hospitals are underrepresented.
Overall, readmission after LE vascular procedures is a complex and multifactorial problem that is difficult to predict. Previous authors have stated that determining the risk of readmission after surgery is difficult to predict at the time of discharge, and that of information available at that time, preoperative factors are the most important. 5 We have demonstrated that disease severity is highly predictive of readmission for both open and endovascular procedures. Chronic conditions, including coronary artery disease, renal disease, hypertension, and hypertensive medications were associated with increased readmission after endovascular procedures, suggesting that more intense medical management in the outpatient setting may reduce future hospital readmission. For patients undergoing LE bypass, receiving blood transfusions, having heart failure, using bronchodilators, and hyponatremia were associated with readmission. Recognition of these risk factors could help providers identify high-risk patients who may benefit from increased surveillance and improved outpatient medical management, and may serve as markers for future discharge programs supporting patients after LE vascular procedures.
